Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 11Urinary Bladder Neoplasms 6Carcinoma, Renal Cell 4Ovarian Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Melanoma 2Lung Neoplasms 2Colonic Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Ureteral Neoplasms 1Stroke 1Stomach Neoplasms 1Sarcoma 1Renal Insufficiency, Chronic 1Recurrence 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Neoplasms 1Myelodysplastic Syndromes 1Localized Prostate Carcinoma 1Leukemia, Myeloid, Acute 1Kidney Failure, Chronic 1Hypogonadism 1Esophageal Neoplasms 1Disease Progression 1Diabetes Mellitus 1Coronary Artery Disease 1

Interventions

Gemcitabine 9pembrolizumab 7Cisplatin 5enfortumab vedotin 4atezolizumab 4Trastuzumab 4Mitomycin 4Carboplatin 4Sunitinib 3Pemetrexed 3dodecyl maltoside 2cabozantinib 2Water 2Sugammadex 2Standard of Care 2Saline Solution 2Paclitaxel 2Nivolumab 2Neostigmine 2Docetaxel 2Cetuximab 2Bevacizumab 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1vinflunine 1valrubicin 1tucatinib 1tislelizumab 1testosterone 17 beta-cypionate 1temsirolimus 1relatlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × Practice Guidelines as Topic × Genitourinary × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡